KRISTIN SCHMIDT: Open Payments
NPI 1578181210 · FLEMING ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,694 in 114 payments from 44 companies in 2025. Trend: 2023 $3,632 · 2024 $2,489 · 2025 $2,694
Food & beverage: $2,694
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $217 |
| Janssen Biotech, Inc. | 7 | $216 |
| MERZ NORTH AMERICA, INC. | 1 | $147 |
| Novartis Pharmaceuticals Corporation | 7 | $121 |
| TerSera Therapeutics LLC | 5 | $120 |
| GENZYME CORPORATION | 5 | $105 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| Merck Sharp & Dohme LLC | 4 | $98 |
| BeOne Medicines USA, Inc. | 4 | $95 |
| Gilead Sciences, Inc. | 4 | $90 |
Products named: Xeomin, Enhertu, Zoladex, EPKINLY, IMFINZI, RYBREVANT, KEYTRUDA, Trodelvy.
Industry payments across FL — which companies pay providers there.
